Onchocerca volvulus‐specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy
暂无分享,去创建一个
D. M. Hamm | P. Soboslay | A. Agossou | M. Banla | C. Heuschkel | C. Mai | H. Schulz‐key
[1] P. Enyong,et al. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Hoerauf,et al. Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin , 2006, Filaria journal.
[3] D. M. Hamm,et al. Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment. , 2006, Microbes and infection.
[4] D. M. Hamm,et al. Chemokines in onchocerciasis patients after a single dose of ivermectin , 2005, Clinical and experimental immunology.
[5] V. Nantulya,et al. Public–private partnerships in blindness prevention: reaching beyond the eye , 2005, Eye.
[6] Linbo Wu,et al. The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa. , 2005 .
[7] F. Richards,et al. Whither onchocerciasis control in Africa? , 2005, The American journal of tropical medicine and hygiene.
[8] C. Nfon,et al. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal. , 2004, International journal for parasitology.
[9] D. Boakye,et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.
[10] D. Boakye,et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.
[11] N. Brattig. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. , 2004, Microbes and infection.
[12] M. Boussinesq,et al. Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon , 2003, Filaria journal.
[13] J. Habbema,et al. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa , 2003, Filaria journal.
[14] C. Mackenzie,et al. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. , 2003, The Journal of infectious diseases.
[15] M. Neira,et al. Final report of the Conference on the eradicability of Onchocerciasis , 2003, Filaria journal.
[16] G. Adeoye,et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC) , 2002, Annals of tropical medicine and parasitology.
[17] Z. Bisoffi,et al. Multicentre study, in patients with imported malaria, on the sensitivity and specificity of a dipstick test (ICT Malaria P.f./P.v.TM) compared with expert microscopy , 2002, Annals of tropical medicine and parasitology.
[18] J. Habbema,et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa? , 2002, Bulletin of the World Health Organization.
[19] P. McKenna,et al. Resistance to macrocyclic lactone anthelmintics by Haemonchus contortus and Ostertagia circumcincta in sheep in New Zealand , 2001, New Zealand veterinary journal.
[20] A. Hoerauf,et al. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment , 2001, The Lancet.
[21] E. Cupp,et al. Programmatic goals and approaches to onchocerciasis , 2000, The Lancet.
[22] P. Enyong,et al. Immunity to Onchocerciasis: Cells from Putatively Immune Individuals Produce Enhanced Levels of Interleukin-5, Gamma Interferon, and Granulocyte-Macrophage Colony-Stimulating Factor in Response to Onchocerca volvulus Larval and Male Worm Antigens , 2000, Infection and Immunity.
[23] T. Nutman,et al. Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis. , 2000, Clinical immunology.
[24] M. Molento,et al. Decreased ivermectin and moxidectin sensitivity in Haemonchus contortus selected with moxidectin over 14 generations. , 1999, Veterinary parasitology.
[25] D. Remick,et al. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin. , 1999, The Journal of infectious diseases.
[26] Ogbuagu,et al. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial , 1998, Tropical medicine & international health : TM & IH.
[27] A. Abiose. Onchocercal eye disease Mectizan treatment and the impact of , 1998 .
[28] A. Abiose. Onchocercal eye disease and the impact of Mectizan treatment. , 1998, Annals of tropical medicine and parasitology.
[29] D. Molyneux,et al. Onchocerciasis control: Moving towards the millennium. , 1997, Parasitology today.
[30] B. Boatin,et al. Twenty-two years of blackfly control in the onchocerciasis control programme in West Africa. , 1997, Parasitology today.
[31] A. Hoerauf,et al. Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals. , 1997, International immunology.
[32] S. Geiger,et al. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection , 1997, Immunology.
[33] J. Habbema,et al. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. , 1997, Bulletin of the World Health Organization.
[34] T. Nutman,et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. , 1995, The Journal of infectious diseases.
[35] T. Nutman,et al. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. , 1994, The Journal of infectious diseases.
[36] C. Dreweck,et al. Ivermectin‐facilitated immunity in onchocerciasis; activation of parasite‐specific Th1‐type responses with subclinical Onchocerca volvulus infection , 1994 .
[37] P. Soboslay,et al. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[38] J. Remmé,et al. Distribution and severity of onchocerciasis in southern Benin, Ghana and Togo. , 1992, Acta tropica.
[39] C. Dreweck,et al. Ivermectin‐facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment , 1992, Clinical and experimental immunology.
[40] P. Soboslay,et al. Ivermectin-facilitated immunity. , 1992, Parasitology today.
[41] T. Nutman,et al. Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. , 1991, The Journal of infectious diseases.
[42] J. Remmé,et al. Onchocerciasis infection in children born during 14 years of Simulium control in West Africa. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[43] B. Duke. Onchocerciasis (river blindness)- can it be eradicated? , 1990, Parasitology today.
[44] G. V. Van Oortmarssen,et al. The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa. , 1990, Bulletin of the World Health Organization.
[45] J. Remmé,et al. Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa. , 1987, Acta tropica.
[46] H. Gilles,et al. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. , 1986, Annals of tropical medicine and parasitology.
[47] J. Ellner,et al. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. , 1983, Clinical and experimental immunology.
[48] D. Büttner,et al. Isolation of living adult Onchocerca volvulus from nodules. , 1977, Tropenmedizin und Parasitologie.
[49] N Katz,et al. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.